General
Preferred name
MINODRONIC ACID
Synonyms
Phosphonicacid,(1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis- ()
ONO-5920 ()
YM-529 ()
Minodronate ()
Minodronic acid (hydrate) ()
Minodronic acid monohydrate ()
YM-529 (hydrate) ()
Acido minodronico ()
Acide minodronique ()
YM 529 ()
YM529 ()
NSC-725590 ()
P&D ID
PD014807
CAS
127657-42-5
180064-38-4
155648-60-5
Tags
available
drug
Approved by
PMDA
First approval
2011
Drug indication
Osteoporosis
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
33
PRICE
33
DESCRIPTION
Minodronic acid(YM-529) is a P2X2/3 receptor antagonist with anticancer activity, directly or indirectly inhibiting the proliferation of cancer cells and inducing apoptosis. Minodronic acid has been shown to inhibit the metastasis of various types of cancer cells.Minodronic-acid has been used in the study of osteoporosis.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Minodronic acid monohydrate is an farnesyl diphosphate synthase inhibitor that acts as a bone resorption inhibitor.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
2
Organisms
0
Compound Sets
16
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
NPC Screening Collection
Probe Miner (suitable probes)
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
64
Molecular Weight
322.01
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
5
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
-0.12
TPSA
152.59
Fraction CSP3
0.22
Chiral centers
0.0
Largest ring
6.0
QED
0.49
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Farnesyl diphosphate synthase
P2X2
P2X3
Apoptosis
FDPS, GGPS1
Farnesyl Transferase
P2X Receptor
NO Synthase
Indication
osteoporosis
MOA
bone resorption inhibitor
Pathway
Metabolism
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Immunology/Inflammation
Neuroscience
Source data

